30 related articles for article (PubMed ID: 7087801)
1. A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection.
Fehér C; Soriano A; Mensa J
Infect Dis Ther; 2017 Mar; 6(1):1-35. PubMed ID: 27910000
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the extracellular proteomes of two Clostridium sordellii strains exhibiting contrasting virulence.
Kachman MT; Hurley MC; Thiele T; Srinivas G; Aronoff DM
Anaerobe; 2010 Aug; 16(4):454-60. PubMed ID: 20338254
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.
Peláez T; Alcalá L; Alonso R; Rodríguez-Créixems M; García-Lechuz JM; Bouza E
Antimicrob Agents Chemother; 2002 Jun; 46(6):1647-50. PubMed ID: 12019070
[TBL] [Abstract][Full Text] [Related]
5. Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile.
Wüst J; Hardegger U
Antimicrob Agents Chemother; 1983 May; 23(5):784-6. PubMed ID: 6870225
[TBL] [Abstract][Full Text] [Related]
6. Effect of L-cysteine on the activity of penicillin antibiotics against Clostridium difficile.
Markowitz SM; Williams DS
Antimicrob Agents Chemother; 1985 Mar; 27(3):419-21. PubMed ID: 3994352
[TBL] [Abstract][Full Text] [Related]
7. Correlation between susceptibility to chloramphenicol, tetracycline and clindamycin, and serogroups of Clostridium difficile.
Nakamura S; Yamakawa K; Nakashio S; Kamiya S; Nishida S
Med Microbiol Immunol; 1987; 176(2):79-82. PubMed ID: 3574240
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis of Clostridium difficile-associated diarrhoea.
Bowman RA; Riley TV
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):476-84. PubMed ID: 3141153
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
Tally FP; Malamy MH
Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
[TBL] [Abstract][Full Text] [Related]
10. Treatment failures secondary to in vivo development of drug resistance by microorganisms.
Sugarman B; Pesanti E
Rev Infect Dis; 1980; 2(2):153-68. PubMed ID: 6771864
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Clostridium difficile from different sources.
Nakamura S; Nakashio S; Mikawa M; Yamakawa K; Okumura S; Nishida S
Microbiol Immunol; 1982; 26(1):25-30. PubMed ID: 7087801
[TBL] [Abstract][Full Text] [Related]
12. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis].
Kobayashi T
Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M
Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652
[TBL] [Abstract][Full Text] [Related]
14. Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile.
Delmée M; Avesani V
J Antimicrob Chemother; 1988 Sep; 22(3):325-31. PubMed ID: 3053559
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of Clostridium species isolated from human infections.
Dornbusch K; Nord CE; Dahlbäck A
Scand J Infect Dis; 1975; 7(2):127-34. PubMed ID: 170668
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
